| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 Feb 25 | RVNC Revance Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 15,000 | 0.00 | 0 |
| 4 Feb 25 | RVNC Revance Therapeutics | Common Stock | Dispose U | No | No | 3.65 | 5,784 | 21.11 k | 15,000 | |
| 5 Jan 25 | BHVN Biohaven | Common Shares | Payment of exercise | Dispose F | No | No | 38.64 | 6,805 | 262.95 k | 1,796,604 |
| 5 Jan 25 | BHVN Biohaven | Common Shares | Option exercise | Acquire M | No | No | 0 | 14,250 | 0.00 | 1,803,409 |
| 5 Jan 25 | BHVN Biohaven | Restricted Share Unit Award Common Shares | Option exercise | Dispose M | No | No | 0 | 14,250 | 0.00 | 42,750 |
| 5 Jan 25 | BHVN Biohaven | Restricted Share Unit Award Common Shares | Grant | Acquire A | No | No | 0 | 57,000 | 0.00 | 57,000 |
| 5 Jan 25 | BHVN Biohaven | Stock Options Common Shares | Grant | Acquire A | No | No | 38.64 | 343,000 | 13.25 mm | 343,000 |
| 2 Oct 24 | BHVN Biohaven | Common Shares | Buy | Acquire P | Yes | No | 47.5 | 21,052 | 999.97 k | 861,942 |
| 1 May 24 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 15,000 | 0.00 | 20,784 |
| 1 May 24 | RVNC Revance Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.795 | 23,458 | 89.02 k | 23,458 |
